Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DRMAW

Dermata Therapeutics, Inc.

CIK 0001853816 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.00
↓ 0.00 (-50.00%)
as of Aug 17, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$2.41K
P/E Ratio
-0.00
EPS
-8.16
Dividend Yield
Not covered
52W Position
0%
Beta
-0.62

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.00
P/S
Not covered
EV/Revenue
Not covered
ROE
-110.8%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

246 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 0%
$0.00$0.03

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$7.56M
Total Assets
$7.86M
Free Cash Flow
–

Recent news